4//SEC Filing
MARCHESI VINCENT T 4
Accession 0000939767-20-000100
CIK 0000939767other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:11 PM ET
Size
13.4 KB
Accession
0000939767-20-000100
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
MARCHESI VINCENT T
Director
Transactions
- Award
Common Stock
2020-05-21+7,728→ 90,212 total - Award
Option (right to buy)
2020-05-21+15,456→ 15,456 totalExercise: $24.62From: 2020-05-21Exp: 2027-05-20→ Common Stock (15,456 underlying) - Sale
Common Stock
2020-05-21$24.64/sh−40,000$985,600→ 90,212 total - Exercise/Conversion
Option (right to buy)
2020-05-21−40,000→ 40,004 totalExercise: $5.82From: 2013-12-06Exp: 2020-12-05→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2020-05-21$5.82/sh+40,000$232,800→ 130,212 total
Footnotes (6)
- [F1]Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
- [F2]The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 21, 2021, subject to the Reporting Person's continuous service through that date.
- [F3]Includes 18,045 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.56 to $25.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
- [F5]Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date.
- [F6]The option, representing the right to purchase a total of 80,004 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001202095
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 9:11 PM ET
- Size
- 13.4 KB